Halozyme Therapeutics, Inc. (FRA:RV7)
55.20
-1.00 (-1.78%)
At close: Dec 4, 2025
19.43% (1Y)
| Market Cap | 6.40B |
| Revenue (ttm) | 1.06B |
| Net Income (ttm) | 507.54M |
| Shares Out | n/a |
| EPS (ttm) | 4.04 |
| PE Ratio | 12.61 |
| Forward PE | 8.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 224 |
| Average Volume | 91 |
| Open | 55.16 |
| Previous Close | 56.20 |
| Day's Range | 54.44 - 55.20 |
| 52-Week Range | 42.45 - 66.90 |
| Beta | n/a |
| RSI | 34.12 |
| Earnings Date | Feb 18, 2026 |